cancer immunotherapylung and colon cancerBTN1A1Galectin-9
…unoregulatory molecule with potential utility as a biomarker in cancer immunotherapy. While previous studies have demonstrated BTN1A1’s role in modu…
18articles mentioning treatments
20treatment mentions
1distinct treatments extracted
0%of mentions human-reviewed
Active filtersEntity: Cancer immunotherapy ×
Cancer immunotherapy
This treatment is selected. Its supporting articles are shown below.
Articles mentioning Cancer immunotherapy
18 articles · page 2 of 2Cancer immunotherapybreast cancerSNUBHhuman breast cancerSeoul National University Bundang HospitalKorea Advanced Institute of Science and Technology
…Background Cancer immunotherapy harnesses the immune system to recognise and eliminate cancer c…
cancer immunotherapycolon cancerICOSL
… immune evasion, thereby significantly limiting the efficacy of cancer immunotherapy. Metabolic regulators are crucial in determining immune cell fa…
cancer immunotherapyIron chelatorshuman cancers
…omplex class I (MHC-I) antigen presentation, which is vital for cancer immunotherapy.Methods Clustered regularly interspaced short palindromic repea…
cancer immunotherapypancreatic cancersolid tumorsgraft-versus-host disease (GvHD)CRSGvHDcytokine release syndromePC
… killer cell properties that make them promising candidates for cancer immunotherapy. However, the therapeutic potential of Vδ1 γδ T cells, particul…
anti-PD therapyCancer immunotherapyTIGITICOSTIM-3hematopoietic malignanciessolid tumors
…often showing minimal clinical benefit even in combination with anti-PD therapy. This article explores three key hypotheses that help explain t…